INM
Price
$2.78
Change
-$0.39 (-12.30%)
Updated
Jul 15, 04:59 PM (EDT)
Capitalization
10.02M
PYPD
Price
$3.50
Change
+$0.11 (+3.24%)
Updated
Jul 15, 04:59 PM (EDT)
Capitalization
34.55M
22 days until earnings call
Interact to see
Advertisement

INM vs PYPD

Header iconINM vs PYPD Comparison
Open Charts INM vs PYPDBanner chart's image
InMed Pharmaceuticals
Price$2.78
Change-$0.39 (-12.30%)
Volume$600
Capitalization10.02M
PolyPid
Price$3.50
Change+$0.11 (+3.24%)
Volume$1.75K
Capitalization34.55M
INM vs PYPD Comparison Chart in %
Loading...
INM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYPD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INM vs. PYPD commentary
Jul 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INM is a Hold and PYPD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 16, 2025
Stock price -- (INM: $3.17 vs. PYPD: $3.39)
Brand notoriety: INM and PYPD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INM: 26% vs. PYPD: 8%
Market capitalization -- INM: $8.78M vs. PYPD: $35.67M
INM [@Biotechnology] is valued at $8.78M. PYPD’s [@Biotechnology] market capitalization is $35.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INM’s FA Score shows that 0 FA rating(s) are green whilePYPD’s FA Score has 0 green FA rating(s).

  • INM’s FA Score: 0 green, 5 red.
  • PYPD’s FA Score: 0 green, 5 red.
According to our system of comparison, both INM and PYPD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INM’s TA Score shows that 4 TA indicator(s) are bullish while PYPD’s TA Score has 2 bullish TA indicator(s).

  • INM’s TA Score: 4 bullish, 6 bearish.
  • PYPD’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, both INM and PYPD are a bad buy in the short-term.

Price Growth

INM (@Biotechnology) experienced а +8.93% price change this week, while PYPD (@Biotechnology) price change was -1.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.54%. For the same industry, the average monthly price growth was +18.40%, and the average quarterly price growth was +31.31%.

Reported Earning Dates

INM is expected to report earnings on May 12, 2025.

PYPD is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+2.54% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PYPD($34.5M) has a higher market cap than INM($10M). PYPD YTD gains are higher at: 11.513 vs. INM (-30.937). INM has higher annual earnings (EBITDA): -7.86M vs. PYPD (-29.31M). PYPD has more cash in the bank: 8.04M vs. INM (4.68M). INM has less debt than PYPD: INM (849K) vs PYPD (8.83M). INM has higher revenues than PYPD: INM (4.92M) vs PYPD (0).
INMPYPDINM / PYPD
Capitalization10M34.5M29%
EBITDA-7.86M-29.31M27%
Gain YTD-30.93711.513-269%
P/E Ratio0.01N/A-
Revenue4.92M0-
Total Cash4.68M8.04M58%
Total Debt849K8.83M10%
FUNDAMENTALS RATINGS
INM: Fundamental Ratings
INM
OUTLOOK RATING
1..100
95
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
83
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INMPYPD
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
83%
N/A
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
INM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYPD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SEI31.800.60
+1.92%
Solaris Energy Infrastructure Inc
OZK52.550.97
+1.88%
Bank OZK
ADEA14.53-0.14
-0.95%
Adeia
INSG7.67-0.17
-2.17%
Inseego Corp
EQNR26.38-0.72
-2.66%
Equinor ASA

INM and

Correlation & Price change

A.I.dvisor indicates that over the last year, INM has been loosely correlated with TTNP. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if INM jumps, then TTNP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INM
1D Price
Change %
INM100%
+15.27%
TTNP - INM
44%
Loosely correlated
+3.07%
HYPD - INM
39%
Loosely correlated
-9.07%
OMER - INM
36%
Loosely correlated
+7.67%
VTYX - INM
31%
Poorly correlated
+2.55%
PULM - INM
30%
Poorly correlated
+3.80%
More

PYPD and

Correlation & Price change

A.I.dvisor indicates that over the last year, PYPD has been loosely correlated with VTYX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if PYPD jumps, then VTYX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYPD
1D Price
Change %
PYPD100%
+0.30%
VTYX - PYPD
37%
Loosely correlated
+2.55%
AMLX - PYPD
29%
Poorly correlated
+9.51%
MESO - PYPD
28%
Poorly correlated
+0.54%
INM - PYPD
28%
Poorly correlated
+15.27%
VRAX - PYPD
28%
Poorly correlated
+2.89%
More